LQDA
LQDA
NASDAQ · Pharmaceuticals

Liquidia Corp

$75.54
+1.50 (+2.03%)
As of Jun 24, 9:58 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target -42.9% upside
Low Target $30.71
Average Target $43.17
High Target $51.56
Current Price $75.54
Current
$75.54
Target
$43.17
$30.71 $43.17 avg $51.56
Scenario Analysis
Bear Case
$30.71
-59.3%
Low target
Base Case
$43.17
-42.9%
Avg target
Bull Case
$51.56
+-31.7%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$73.22
3.2% from high
52-Week Low
$11.85
+537.5% from low
50-Day SMA
$37.31
+102.5% vs SMA
200-Day SMA
$25.48
+196.5% vs SMA
RSI (14)
31.7
Neutral
Target vs 52W High
$43.17
-41.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.1%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +32.1%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +41.0%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%